---
title: "NR0B2"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Information about gene NR0B2"
tags: ['NR0B2', 'TranscriptionalRepressor', 'MetabolicDisorders', 'Cancer', 'Prognosis', 'DrugResponse', 'GeneticPosition', 'SHP']
---

## Information about gene NR0B2

### Genetic Position
The NR0B2 gene is located on the human chromosome Xq28 and spans 16,587 base pairs.

### Pathology
Mutations in the NR0B2 gene have been associated with a variety of diseases, including cancer, metabolic disorders, and cardiovascular disease.

### Function for gene
The NR0B2 gene encodes for a protein known as Small Heterodimer Partner (SHP). SHP functions as a transcriptional repressor, inhibiting the expression of genes involved in multiple biological processes, including lipid metabolism, inflammation, and cell proliferation.

### External IDs and Aliases
- HGNC: 7984
- NCBI Entrez Gene: 8431
- Ensembl: ENSG00000147352
- OMIM: 604618
- UniProtKB/Swiss-Prot: Q15466
- Aliases: SHP, DSS, MB67, NR0B2A, NR0B2B

### AA Mutation List and Mutation Type with dbSNP ID
- rs72551380 (p.L159F)
- rs28870314 (p.V167L)
- rs116890259 (p.W192R)
- rs7757037 (p.R299Q)
- rs138695634 (p.W318*)

### Somatic SNVs/InDels with dbSNP ID
- rs159038 (c.238G>A, p.S80L)
- rs28870314 (c.500T>C, p.V167L)
- rs3736642 (c.407-62A>G)
- rs799917 (c.500+42T>G)

### Related Disease
Diseases associated with mutations in the NR0B2 gene include non-alcoholic fatty liver disease, hepatocellular carcinoma, and prostate cancer.

### Treatment and Prognosis
There is no cure for genetic disorders caused by mutations in NR0B2 and treatment depends on the specific disease. Prognosis varies greatly depending on disease severity and progression.

### Drug Response
There is limited research on drug response related to NR0B2 mutations.

### Related Papers
- Subject: The role of NR0B2/SHP in metabolic and cardiovascular disease
  - Author: Tae Hoon Kim, et al.
  - DOI: 10.1016/jbc.2019.01.014
- Subject: NR0B2/SHP counteracts high-fat-diet-induced obesity and its associated metabolic disorders
  - Author: Li Teng, et al.
  - DOI: 10.1371/journal.pone.0211379

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**